Sotyktu’s Psoriatic Arthritis Launch Builds Gradually in Month Two as Rheumatologists Continue to Take Measured Approach to TYK2 Adoption, Accordin…

Despite incremental gains in awareness and prescribing, most launch metrics continue to trail recent rheumatology benchmarks, ...

The Ghost Condition: What It's Actually Like To Have Invisible Arthritis

Autoimmune and autoinflammatory arthritis are often called "invisible illnesses" because many patients may appear healthy on the outside while silently battling chronic pain, fatigue, stiffness, and ...

UCB says Bimzelx beat AbbVie’s Skyrizi in psoriatic arthritis trial

AbbVie (ABBV) stock is in focus as UCB's Bimzelx beats the company's immunology blockbuster Skyrizi in head-to-head trial for ...

Managing arthritis: Three pillars of care and practical strategies

Arthritis can limit daily activities, but the Aging Untold experts say there are effective ways to manage symptoms and ...
PharmaTimes

UCB reports positive outcomes for bimekizumab in psoriatic arthritis

UCB has announced new week 16 results from the phase 3 BE BOLD trial showing that bimekizumab delivered superior joint ...